A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS.

Yoshiyuki MiyazawaToshiyuki NakamuraYutaka TakezawaNobuaki ShimizuYasushige MatsuoHaruyuki OguraTomoyuki TakeiYoshitaka SekineSeiji AraiKazuhiro Suzuki

Published in: The Prostate (2023)

The serum T level before treatment may be useful for predicting QoL changes after ENZ treatment in CRPC patients.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
replacement therapy
case report
peritoneal dialysis
patient reported outcomes